Temporal trends in lung cancer survival: a population-based study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–241.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen – Swedish National Board of Health and Welfare. Statistics on cancer incidence 2018. Stockholm, Sweden; 2019.
   Google Scholar
• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–1075.
   PubMed Web of Science ®Google Scholar
• Regional Cancer Centre – Central Sweden. Lung cancer – National quality report, 2012-2016 Uppsala, Sweden; 2017. Available from: https://cancercentrum.se/globalassets/cancerdiagnoser/lunga-och-lungsack/kvalitetsregister/rapport/nlcr_rapport_tom2016_171120_publicera.pdf
   Google Scholar
• Regionala Cancercentrum i Samverkan. Nationellt vårdprogram – Lungcancer [national care program – Lung cancer]. 4.0 ed. Uppsala, Sweden; 2020. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/lunga-och-lungsack/vardprogram/nationellt-vardprogram-lungcancer.pdf
   Google Scholar
• Löfling L, Karimi A, Sandin F, et al. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study. Acta Oncol. 2019;58(11):1618–1627.
   PubMed Web of Science ®Google Scholar
• Willén L, Berglund A, Bergström S, et al. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study. Lung Cancer. 2019;131:40–46.
   PubMed Web of Science ®Google Scholar
• Löfling L, Bahmanyar S, Kieler H, et al. Antibiotic use prior to a lung cancer diagnosis: a population-based study. Cancer Causes Control. 2021;32(6):597–607.
   PubMed Web of Science ®Google Scholar
• Regional Cancer Centre – Central Sweden. Swedish National Lung Cancer Register 2017 [170913]. Available from: http://www.cancercentrum.se/vast/cancerdiagnoser/lunga-och-lungsack/kvalitetsregister/
   Google Scholar
• Socialstyrelsen – Swedish National Board of Health and Welfare. The Swedish Cancer Register 2019 [updated 20190509;191122]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/swedish-cancer-register/
   Google Scholar
• Socialstyrelsen -Swedish National Board of Health and Welfare. The Swedish National Patient Register Socialstyrelsen -Swedish National Bord of Health and Welfare; 2019. [updated 20190520;191122]. Available from: https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/the-national-patient-register/.
   Google Scholar
• Socialstyrelsen – Swedish National Board of Health and Welfare. The Swedish Prescribed Drug Register: Socialstyrelsen – Swedish National Board of Health and Welfare; 2019 [updated 20191018;191122]. Available from: https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/lakemedelsregistret/.
   Google Scholar
• Socialstyrelsen – Swedish National Board of Health and Welfare. The Swedish Cause of Death Register: Socialstyrelsen -Swedish National Bord of Health and Welfare; 2019. [updated 20191018;191122]. Available from: https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/dodsorsaksregistret/.
   Google Scholar
• Statistiska Centralbyrån (SCB) -Statistics Sweden. The Swedish Multi-generation Register 2016 [20171016]. Available from: https://www.scb.se/sv_/Vara-tjanster/Bestalla-mikrodata/Vilka-mikrodata-finns/Flergenerationsregistret/.
   Google Scholar
• Skatteverket – The Swedish Tax Agency. The Swedish Population Register 2020 200604. Available from: https://www.skatteverket.se/privat/folkbokforing/attvarafolkbokford/folkbokforingsdatabasen.4.3810a01c150939e893f16fe2.html.
   Google Scholar
• Statistiska Centralbyrån (SCB) -Statistics Sweden. Longitudinal Integration Database for Health Insurance and Labour Market Studies (LISA) 2016 [20171026]. Available from: https://www.scb.se/contentassets/f0bc88c852364b6ea5c1654a0cc90234/dokumentation-av-lisa.pdf.
   Google Scholar
• Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, et al. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24(11):659–667.
   PubMed Web of Science ®Google Scholar
• Regional Cancer Centre – Central Sweden. Swedish National Lung Cancer Register – Validation project. 2016.
   Google Scholar
• Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15(1):186–215.
   Web of Science ®Google Scholar
• Human Mortality Database Team. Human Mortality Database [cited 2020 200430]. Available from: https://www.mortality.org
   Google Scholar
• Association of the Nordic Cancer Registers (NORDCAN). Glossary of statistical terms Lyon, France: International Agency for Research on Cancer (IARC); 2011. [cited 2019 20190716]. Available from: http://www-dep.iarc.fr/NORDCAN/english/glossary.htm
   Google Scholar
• R Development Core Team. R: a language and enviroment for statistical computing. 4.0.0. Vienna, Austria: R Foundation for statistical computing; 2020.
   Google Scholar
• StataCorp. Stata statistical software. 16.1. College station. Texas, United States of America: StataCorp; 2020.
   Google Scholar
• Lundberg FE, Andersson TML, Lambe M, et al. Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies. Acta Oncol. 2020;59(11):1266–1274.
   PubMed Web of Science ®Google Scholar
• Brustugun OT, Grønberg BH, Fjellbirkeland L, et al. Substantial nation-wide improvement in lung cancer relative survival in Norway from 2000 to 2016. Lung Cancer. 2018;122:138–145.
   PubMed Web of Science ®Google Scholar
• Innos K, Oselin K, Laisaar T, et al. Patterns of survival and surgical treatment in lung cancer patients in Estonia by histologic type and stage, 1996-2016. Acta Oncol. 2019;58(11):1–8.
   Web of Science ®Google Scholar
• Nilssen Y, Strand TE, Fjellbirkeland L, et al. Lung cancer survival in Norway, 1997-2011: from nihilism to optimism. Eur Respir J. 2016;47(1):275–287.
   PubMed Web of Science ®Google Scholar
• Brooks DR, Klint Å, Dickman PW, et al. Temporal trends in non-small cell lung cancer survival in Sweden. Br J Cancer. 2007;96(3):519–522.
   PubMed Web of Science ®Google Scholar
• Statistiska Centralbyrån (SCB) -Statistics Sweden. Färre röker, fler snusar 2018 [20210222]. Available from: https://www.scb.se/hitta-statistik/artiklar/2018/farre-roker-fler-snusar/
   Google Scholar
• Nyman J, Hallqvist A, Lund JA, et al. SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC. Radiother Oncol. 2016;121(1):1–8.
   PubMed Web of Science ®Google Scholar
• Haque W, Verma V, Polamraju P, et al. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer. Radiotherapy and Oncology. 2018;129(2):264–269. Nov
   PubMed Web of Science ®Google Scholar
• Donington JS, Colson YL. Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2011;23(2):137–145.
   PubMedGoogle Scholar
• Isaksson S, Hazem B, Jönsson M, et al. Clinical utility of targeted sequencing in lung cancer: experience from an autonomous Swedish Health Care Center. JTO Clin Res Rep. 2020;1(1):100013.
   PubMedGoogle Scholar
• Du X, Shao Y, Qin H-F, et al. ALK-rearrangement in non-small-cell lung cancer (NSCLC). Thorac Cancer. 2018;9(4):423–430.
   PubMed Web of Science ®Google Scholar
• Schabath MB, Thompson ZJ, Gray JE. Temporal trends in demographics and overall survival of non-small-cell lung cancer patients at Moffitt Cancer Center from 1986 to 2008. Cancer Control: Journal of the Moffitt Cancer Center. 2014;21(1):51–56.
   PubMed Web of Science ®Google Scholar
• Garon EB, Hellmann MD, Rizvi NA, et al. Five-Year overall survival for patients with advanced non‒small-cell lung cancer treated with pembrolizumab: results from the phase I KEYNOTE-001 study. J Clin Oncol. 2019;37(28):2518–2527.
   PubMed Web of Science ®Google Scholar
• Regionala Cancercentrum i Samverkan. Nationellt vårdprogram – Lungcancer [National care program – Lung cancer] Uppsala, Sweden. 2021; 5.0. Available from: https://kunskapsbanken.cancercentrum.se/globalassets/cancerdiagnoser/lunga-och-lungsack/vardprogram/nationellt-vardprogram-lungcancer.pdf
   Google Scholar
• Hinchliffe SR, Rutherford MJ, Crowther MJ, et al. Should relative survival be used with lung cancer data?. Br J Cancer. 2012;106(11):1854–1859.
   PubMed Web of Science ®Google Scholar
• American Joint Committee on Cancer. AJCC cancer staging manual. 7th edition. 7th ed. New York: Springer Verlag New York Inc; 2010.
   Google Scholar